Seeking Alpha · IMRX · November 12, 2026

Immuneering Corporation (IMRX) Discusses Expanded Atebimetinib Development: Pancreatic and Anaplastic Thyroid Cancer Trials Transcript

Get the app for more

Explore stock news, insights and company research.